⌘K

Login Start Free

Home/Filings/4/0001615774-15-001309

4//SEC Filing

CALMARE THERAPEUTICS Inc 4

Accession 0001615774-15-001309

CIK 0000102198operating

View on SEC.gov Company Profile

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 10:56 AM ET

Size

6.9 KB

Accession

0001615774-15-001309

Insider Transaction Report

Form 4

Period: 2015-01-02

CALMARE THERAPEUTICS IncCTTC

Director

Transactions

Award
Common Stock
2015-01-02+2,500→ 138,242 total
Award
Options
2015-01-02+10,000→ 135,238 total
Exercise: $0.17From: 2015-01-02Exp: 2019-01-02→ Common stock, par value $0.01 per share (10,000 underlying)

Footnotes (1)

[F1]Includes 40,000 stock options and the right to acquire an additional 95,238 shares upon conversion of $100,000 of convertible debt.

Documents

1 file

4
s101228_form4.xmlPrimary
4

Issuer

CALMARE THERAPEUTICS Inc

CIK 0000102198

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000102198

Filing Metadata

Form type: 4
Filed: May 31, 8:00 PM ET
Accepted: Jun 1, 10:56 AM ET
Size: 6.9 KB

View on SEC.gov